Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair
In demyelinating disorders such as Multiple Sclerosis (MS), targets of injury are myelin and oligodendrocytes, leading to severe neurological dysfunction. Regenerative therapies aimed at promoting oligodendrocyte maturation and remyelination are promising strategies for treatment in demyelinating di...
Main Authors: | Jennifer K. Sabo, Holly S. Cate |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/1/1031 |
Similar Items
-
Mitochondria in Myelinating Oligodendrocytes: Slow and Out of Breath?
by: Niklas Meyer, et al.
Published: (2021-06-01) -
PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination
by: Yan Wang, et al.
Published: (2021-10-01) -
Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
by: Irene Chacon-De-La-Rocha, et al.
Published: (2020-12-01) -
Niche derived oligodendrocyte progenitors: a source of rejuvenation or complementation for local oligodendrogenesis?
by: Sylvia eAgathou, et al.
Published: (2013-10-01) -
Alteration of Synaptic Connectivity of Oligodendrocyte Precursor Cells Following Demyelination
by: Aurélia eSahel, et al.
Published: (2015-03-01)